SCHEMBL7966864

SCHEMBL7966864

COC(=O)c1cccc2c1nc(C(N)=O)n2Cc1ccc(OC)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 3/20 0.51
GAA P10253 3/20 0.49
KDM4E B2RXH2 2/20 0.49
ALDH1A1 P00352 2/20 0.49
GLA P06280 2/20 0.49
HPGD P15428 2/20 0.49
CASP1 P29466 2/20 0.49
CASP7 P55210 2/20 0.49
HSD17B10 Q99714 2/20 0.49
TSPO P30536 2/20 0.47
CD38 P28907 1/20 0.46
DCTPP1 Q9H773 1/20 0.46
AURKA O14965 2/20 0.44
RPS6KB1 P23443 2/20 0.44
PKN1 Q16512 1/20 0.44
PKN2 Q16513 1/20 0.44
P2RX7 Q99572 3/20 0.43
LMNA P02545 1/20 0.43
TP53 P04637 1/20 0.43
MAPK1 P28482 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7954430 0.90 PARP1 (0.52) PARP1GAAKDM4EALDH1A1GLA
SCHEMBL7427558 0.88 TSPO (0.47) PARP1GAAKDM4EALDH1A1GLA
SCHEMBL7966547 0.87 TSPO (0.54) GAAKDM4EALDH1A1GLAHPGD
SCHEMBL7483323 0.80 TSPO (0.47) GAAKDM4EALDH1A1GLAHPGD
SCHEMBL7965376 0.77 TSPO (0.54) PARP1KDM4EALDH1A1TSPODCTPP1
SCHEMBL7966866 0.76 CCR2 (0.46) GAAKDM4EALDH1A1GLAHPGD
SCHEMBL1201709 0.76 ALDH1A1 (0.47) GAAKDM4EALDH1A1GLAHPGD
SCHEMBL28398222 0.75 L3MBTL1 (0.50) GAAALDH1A1
SCHEMBL8600049 0.73 KDM4E (0.51) PARP1GAAKDM4EALDH1A1GLA
SCHEMBL8601846 0.72 PPARG (0.48) GAAKDM4EALDH1A1GLAHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6316482-B1 FOR THERAPY AND PROPHYLAXIS OF HYPERTENSION, HEART FAILURE, RENAL INSUFFICIENCY, EDEMA, ASCITES, VASOPRESSIN PARASECRETION SYNDROME, HEPATOCIRRHOSIS, HYPONATREMIA, HYPOKALEMIA, DIABETIC, CIRCULATION DISORDER, CEREBROVASCULAR DISEASE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-11-13 US disclosed
US-6207693-B1 Benzamide derivatives having a vasopressin antagonistic activity FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-03-27 US disclosed